8-K
filed August 6, 2024, 7:59 PM ET
ticker MD
CIK 0000893949
earnings
confidence high
sentiment negative
materiality 0.65
Pediatrix Medical Group Q2 net loss $153M (-$1.84/share); Adjusted EPS $0.34 vs $0.39; CFO transition planned
Pediatrix Medical Group, Inc.
2024-Q2 EPS reported
-$1.79
revenue$999,397,000
- Q2 net loss $153M ($1.84 loss per share) vs net income $28.3M ($0.34 EPS) in Q2 2023, driven by $192.9M impairment.
- Adjusted EPS fell to $0.34 from $0.39; Adjusted EBITDA $57.9M vs $59.1M. Revenue $504.3M (+0.7% YoY).
- Company exits office-based and primary/urgent care practices; expects ~$30M annualized EBITDA benefit; guidance reaffirmed $200-220M.
- CFO transition: Kasandra Rossi appointed to succeed Marc Richards effective ~Oct 1, 2024.
- Mary Ann Moore appointed CAO; Dr. Curtis Pickert transitions from COO to Chief Physician Executive (no longer exec officer).
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
C. Marc Richards was terminated as Executive Vice President, Chief Financial Officer and Treasurer at Pediatrix Medical Group, Inc..
- Action
- terminated
- Role
- Executive Vice President, Chief Financial Officer and Treasurer
Exact text from the filing
Mr. Richards’ transition from his role as Executive Vice President, CFO and Treasurer is a termination without “Cause” pursuant to that certain Amended and Restated Employment Agreement
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Kasandra Rossi was appointed as Executive Vice President, Chief Financial Officer and Treasurer at Pediatrix Medical Group, Inc..
- Action
- appointed
- Role
- Executive Vice President, Chief Financial Officer and Treasurer
Exact text from the filing
On August 6, 2024, the Company announced that its board of directors (the “Board”) has appointed Ms. Kasandra Rossi, who currently serves as the Company’s Senior Vice President, Financial Reporting and Assistant Treasurer, to succeed Mr. C. Marc Richards as Executive Vice President, Chief Financial Officer (“CFO”) and Treasurer of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Curtis B. Pickert changed role as Executive Vice President, Chief Physician Executive at Pediatrix Medical Group, Inc..
- Action
- transitioned
- Role
- Executive Vice President, Chief Physician Executive
Exact text from the filing
the Company announced that Curtis B. Pickert, M.D. has transitioned from his role as the Company’s Executive Vice President, Chief Operating Officer and will now serve as Pediatrix’s Executive Vice President, Chief Physician Executive, effective as of August 1, 2024.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Mary Ann E. Moore was appointed as Chief Administrative Officer at Pediatrix Medical Group, Inc..
- Action
- appointed
- Role
- Chief Administrative Officer
Exact text from the filing
The Company also announced that the Board has appointed Ms. Mary Ann E. Moore to serve as the Company’s Chief Administrative Officer, in addition to her existing roles as the Company’s Executive Vice President, General Counsel and Secretary, effective as of August 1, 2024.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.